• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-025
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Complete Heart Block (2627)
Event Date 10/30/2019
Event Type  Injury  
Manufacturer Narrative
An event of the off-label use of an amplatzer pfo, heart block, and removal of the device was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note per the instructions for use, artus600609-001 revision d "the amplatzer¿ pfo occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (pfo)." and "the safety and effectiveness of the amplatzer¿ pfo occluder has not been established in patients with age less than 18 years or greater than 60 years.".
 
Event Description
On (b)(6) 2019, the patient was evaluated for atrial septal defect closure.The physician had initially intended to use a non-abbott gore occluder, but the user elected to forgo that device due to the less than favorable wire position.A 25 mm amplatzer pfo occluder was then selected, for off-label use.The device was successfully positioned, deployed, and released, but immediately following the release the patient developed 3rd degree heart block.The user decided to remove the device.While prepping the snare, the heart rhythm changed to 2nd degree heart block for which medication was administered.Then while attempting to snare the device the patient reverted to normal sinus rhythm.It was then decided to leave the device in place; however, that evening the patient went into 2nd degree heart block.The following morning, the device was successfully snared and the patient reverted back to sinus rhythm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9320828
MDR Text Key166526425
Report Number2135147-2019-00375
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PFO-025
Device Catalogue Number9-PFO-025
Device Lot Number7132340
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/30/2019
Initial Date FDA Received11/14/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/13/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age11 MO
Patient Weight8
-
-